IDEA-FAST and Mobilise-D join forces to strengthen research and development of digital biomarkers

From January 2021 onwards, two EU Innovative Medicines Initiatives, IDEA-FAST and Mobilise-D, will join forces to increase the impact and the benefits of digital health technologies developed by both projects.


The IDEA-FAST project is a 5½-year IMI2 project under Call H2020-JTI-IMI2-2018-15-two-stage – digital endpoints in neurodegenerative and immune-mediated diseases (total budget €42 Million). It received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853981. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.